Aclaris Therapeutics (ACRS) Other Non-Current Liabilities (2014 - 2026)
Aclaris Therapeutics' Other Non-Current Liabilities came in at $11.3 million for Q2 2026, up 7.6% from $10.5 million a year earlier and up 2.7% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Other Non-Current Liabilities (2014 - 2026) Analysis & Trends
At the end of FY2025, Aclaris Therapeutics' Other Non-Current Liabilities was $11 million, up 26.4% from FY2024.
- Other Non-Current Liabilities carries a five-year compound annual growth rate of 22.1% (FY2020 to FY2025).
- Going back by year, Other Non-Current Liabilities was $8.7 million in FY2024 (+40.3%), $6.2 million in FY2023 (-81.3%), $33.1 million in FY2022 (+16.5%) and $28.4 million in FY2021 (+599.3%).
- The Q2 2026 figure represents the highest quarterly Other Non-Current Liabilities since Q3 2023.
- Year-over-year, Other Non-Current Liabilities has increased for five consecutive quarters, with growth averaging 5.9% over the last eight quarters.
- The fastest year-over-year change in Other Non-Current Liabilities over five years came in Q4 2021 (growth of 599.3%), and the weakest in Q4 2023 (a decline of 81.3%).
- Business Quant data shows ACRS's Other Non-Current Liabilities at $11 million (Q1 2026), $11 million (Q4 2025) and $10.6 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Aclaris Therapeutics | 735.48 Mn | 735.48 Mn | 1.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.30 Mn |
| Mar 31, 2026 | 11.00 Mn |
| Dec 31, 2025 | 11.00 Mn |
| Sep 30, 2025 | 10.60 Mn |
| Jun 30, 2025 | 10.50 Mn |
| Mar 31, 2025 | 9.00 Mn |
| Dec 31, 2024 | 8.70 Mn |
| Sep 30, 2024 | 10.00 Mn |
| Jun 30, 2024 | 9.20 Mn |
| Mar 31, 2024 | 9.00 Mn |
| Dec 31, 2023 | 6.20 Mn |
| Sep 30, 2023 | 32.50 Mn |
| Jun 30, 2023 | 30.80 Mn |
| Mar 31, 2023 | 32.30 Mn |
| Dec 31, 2022 | 33.10 Mn |
| Sep 30, 2022 | 26.00 Mn |
| Jun 30, 2022 | 23.80 Mn |
| Mar 31, 2022 | 27.20 Mn |
| Dec 31, 2021 | 28.40 Mn |
| Sep 30, 2021 | 26.20 Mn |
API Access
Aclaris Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();